The specific role of LECs in the progression of GC: as previously mentioned, LECs can participate in various adverse prognosis of cancer through a variety of molecules (VEGFC, VEGFR3 and chemokines, etc.)or signaling pathways (TGF-β, etc.). This evidence concerns the gene FLT4 and gastric cancer.